推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

SEMINARS IN CANCER BIOLOGY

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 SEMIN CANCER BI最新评论:谷歌翻译。 (2021-12-30)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


SEMINARS IN CANCER BIOLOGY期刊基本信息Hello,您是该期刊的第46715位访客


基本信息 登录收藏
期刊名字SEMINARS IN CANCER BIOLOGYSEMINARS IN CANCER BIOLOGY

SEMIN CANCER BIOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.9
50人评分
我要评分

声誉
10.0

影响力
8.4

速度
7.0

期刊ISSN1044-579X
微信扫码收藏此期刊
E-ISSN1096-3650
2023-2024最新影响因子
(数据来源于搜索引擎)
12.1 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:11.825
2023-2024自引率2.50%点击查看自引率趋势图
五年影响因子13.2
JCI期刊引文指标 3.32
h-index 134
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
26.803.2972.178
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q111 / 230

期刊简介
Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.
期刊官方网站http://www.journals.elsevier.com/seminars-in-cancer-biology/
期刊投稿网址https://www.editorialmanager.com/YSCBI
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足SEMINARS IN CANCER BIOLOGY的语言要求,还能让SEMINARS IN CANCER BIOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被SEMINARS IN CANCER BIOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX
出版商Academic Press Inc.
涉及的研究方向医学-肿瘤学
出版国家或地区ENGLAND
出版语言English
出版周期Bimonthly
出版年份1990
年文章数 83点击查看年文章数趋势图
Gold OA文章占比28.83%
研究类文章占比:
文章 ÷(文章 + 综述)
96.39%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ121/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ115/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区1区3区
ONCOLOGY
肿瘤学
2区3区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
ONCOLOGY
肿瘤学
4区1区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
ONCOLOGY
肿瘤学
1区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1044-579X%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
来源Elsevier官网:
平均15.1周
平均录用比例网友分享经验:
较难
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在SEMINARS IN CANCER BIOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 SEMINARS IN CANCER BIOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 SEMINARS IN CANCER BIOLOGY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
SEMINARS IN CANCER BIOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    CLINICAL CANCER RESEARCH29220.10
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677700
    BIOMATERIALS567285
    BIOMEDICINE & PHARMACOTHERAPY552018
    Frontiers in Pharmacology515786
    Journal of Materials Chemistry B506974
    Frontiers in Immunology492571
    COMPUTERS IN BIOLOGY AND MEDICINE474436
    JOURNAL OF ETHNOPHARMACOLOGY466711
    COLLOIDS AND SURFACES B-BIOINTERFACES438831
    Frontiers in Oncology436521
  •  

    SEMINARS IN CANCER BIOLOGY SEMINARS IN CANCER BIOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Holistic immunomodulation for small cell lung cancer

    Author: Leung, Elaine Lai-Han; Fan, Xing-Xing; Huang, Ju-Min; Huang, Chen; Lin, Hong; Cao, Ya-Bing
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 88, Issue , pp. 96-105. DOI: 10.1016/j.semcancer.2022.11.012
        PubMed      DOI
    2.CDK inhibitors from past to present: A new wave of cancer therapy

    Author: Mughal, Muhammad Jameel; Bhadresha, Kinjal; Kwok, Hang Fai
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 88, Issue , pp. 106-122. DOI: 10.1016/j.semcancer.2022.12.006
        PubMed      DOI
    3.The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment

    Author: Zhu, Mengxuan; Li, Suyao; Cao, Xin; Rashid, Khalid; Liu, Tianshu
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 88, Issue , pp. 18-31. DOI: 10.1016/j.semcancer.2022.11.011
        PubMed      DOI
    4.Status quo of Extracellular Vesicle isolation and detection methods for clinical utility

    Author: Visan, Kekoolani S.; Wu, Li-Ying; Voss, Sarah; Wuethrich, Alain; Moeller, Andreas
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 88, Issue , pp. 157-171. DOI: 10.1016/j.semcancer.2022.12.008
        PubMed      DOI
    5.Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective

    Author: Huang, Shigao; Yang, Jie; Shen, Na; Xu, Qingsong; Zhao, Qi
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 89, Issue , pp. 30-37. DOI: 10.1016/j.semcancer.2023.01.006
        PubMed      DOI
    6.Artificial intelligence aids in development of nanomedicines for cancer management

    Author: Tan, Ping; Chen, Xiaoting; Zhang, Hu; Wei, Qiang; Luo, Kui
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 89, Issue , pp. 61-75. DOI: 10.1016/j.semcancer.2023.01.005
        PubMed      DOI
    7.Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology

    Author: Shao, Jun; Ma, Jiechao; Zhang, Qin; Li, Weimin; Wang, Chengdi
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 91, Issue , pp. 1-15. DOI: 10.1016/j.semcancer.2023.02.006
        PubMed      DOI
    8.Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer

    Author: Li, Junyu; Li, Lin; You, Peimeng; Wei, Yiping; Xu, Bin
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 91, Issue , pp. 35-49. DOI: 10.1016/j.semcancer.2023.02.009
        PubMed      DOI
    9.Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction

    Author: Li, Tong; Li, Yupeng; Zhu, Xiaoyi; He, Yao; Wu, Yanling; Ying, Tianlei; Xie, Zhi
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 91, Issue , pp. 50-69. DOI: 10.1016/j.semcancer.2023.02.007
        PubMed      DOI
    10.Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma

    Author: Luo, Jiefeng; Pan, Mika; Mo, Ke; Mao, Yingwei; Zou, Donghua
    Journal: SEMINARS IN CANCER BIOLOGY. 2023; Vol. 91, Issue , pp. 110-123. DOI: 10.1016/j.semcancer.2023.03.006
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共9


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室